<!DOCTYPE html>
<html>
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta name="viewport"content="target-densitydpi=device-dpi, initial-scale=1.0,user-scalable=no"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/style.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/estilos.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/flaticon.css"/>
	<script type="text/javascript" src="../assets/js/jquery.js"></script>
	<script type="text/javascript" src="../assets/js/functions.js"></script>
</head>
<body>
	<div id="contenedor">
		<div id="menu_slide">
			<div id="as" class="fonts_i"><i class="flaticon-text162"></i></div>
			<div class="fonts_i"><input type="range" id="slide" min="0" max="72" value="0"></div>
			<div id="am" class="fonts_i"><i class="flaticon-edit-text"></i></div>
		</div>
		<div id="btn_opciones"><i class="flaticon-font14 fonts"></i></div>
		<div id="menu_botones">
			<div class="menu_contenedor">
				<div id="btn_normal" class="botones-caja-lector"></div>
				<div id="btn_sepia" class="botones-caja-lector"></div>
				<div id="btn_noche" class="botones-caja-lector"></div>
			</div>
			<div class="menu_contenedor">
				<select id="select_font">
					<option value="arial">Arial</option>
					<option value="century">New Century</option>
					<option value="futura">Futura</option>
					<option value="gillsans">Gill Sans</option>
					<option value="RobotoLight">Roboto</option>
					<option value="timesNew">Times New Roman</option>
				</select>
			</div>
		</div>
		<div id="contenedor-texto">
			<h1 id="subtitulo">4. Kidney changes in patients with DN</h1>
			<p>
				<ul>
				 	<li><b>Structural changes:</b> glomerular hypertrophy, hypertrophy of mesangial cells, thickening of the glomerular basement membrane, matrix accumulation.<sup>1</sup></li>
				 	<li><b>Functional changes:</b></li>
			 		<ul>
			 			<li><b>Glomerular hyperfiltration: </b>defined as glomerular filtration rate greater than 150 mL/min.<sup>1</sup> The first changes of DN include glomerular hyperfiltration and renal hypertrophy.<sup>1</sup></li>
			 			<li><b>Microalbuminuria: </b>corresponds to urinary albumin between 30-300 mg/day; 20-200 μg/min. or 30-300 mg/g in albumin/creatinine ratio.<sup>5</sup></li>
			 			<li><b>Macroalbuminuria: </b>if albumin concentration > 300 mg/day; > 200 μg/min. or > 300 mg/g in albumin/creatinine ratio.<sup>5</sup></li>
			 			<li><b>Proteinuria: </b>is concentration > 300 mg/day or > 200 μg/min. of any protein in urine.<sup>5</sup></li>
			 		</ul>
				 </ul>
				 <p>
				 	The cause of microalbuminuria is altered synthesis of proteoglycans of the extracellular matrix (mesangium and basement membrane) with changes in electrical membrane composition and leakage of albumin.<sup>1</sup>
					<br>
					<br>
				 	<b>Microalbuminuria is the first clinical manifestation of DN.<sup>1</sup></b> It may initially be intermittent and associated with exercise; if microalbuminuria becomes persistent, it can be demonstrated by urine test. Persistent microalbuminuria is established when 2 / 3 or 3 tests are positive for microalbuminuria, within a sampling period ranging between 3 and 6 months.<sup>1</sup>
					<br>
					<br>
				 	Microalbuminuria is associated with increased cardiovascular risk; the association between DN and cardiovascular risk is continuous.<sup>6</sup> People with microalbuminuria have twice the cardiovascular risk than people with normoalbuminuria.<sup>6</sup>
					<br>
					<br>
				 	<b>Persistent proteinuria is associated with</b> decreased GFR, hypertension, poor prognosis and progressive deterioration of renal function.<sup>1</sup>
				 </p>
			</p>
		</div>
	</div>
</body>
</html>